Alexander Eggermont
Active 1992–2026
- 86
- Papers
- 27,720
- Citations
- 75
- h-index
- 83
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine41.3%
- Biochemistry, Genetics and Molecular Biology36.7%
- Immunology and Microbiology14.5%
- Engineering2.1%
- Materials Science1.2%
- Neuroscience0.9%
- Other3.3%
Topics
- Cancer Immunotherapy and Biomarkers10.1%
- Gut microbiota and health7.8%
- Immunotherapy and Immune Responses5.9%
- Immune Cell Function and Interaction3.6%
- CAR-T cell therapy research3%
- Immune cells in cancer2.9%
- Other66.7%
Coauthors
- Laurence Zitvogel35
- Guido Kroemer34
- Lorenzo Galluzzi28
- Jérôme Galon25
- Erika Vacchelli23
- Éric Tartour17
- Catherine Sautès‐Fridman15
- Wolf H. Fridman15
- Isabelle Cremer12
- Fernando Aranda11
- Norma Bloy8
- Caroline Flament7
- Connie P.M. Duong7
- Jean‐Charles Soria7
- Jitka Fučíková7
- Aitziber Buqué6
- Aurélien Marabelle6
- Bertrand Routy6
- Nicolas Jacquelot6
- Romain Daillère6
- Sylvie Rusakiewicz6
- Timo L.M. ten Hagen6
- Caroline Robert5
- David Enot5
All papers
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
Authors: Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa, Connie P.M. Duong, Maryam Tidjani Alou, Romain Daillère, Aurélie Fluckiger, Meriem Messaoudene, Conrad Rauber, María Paula Roberti, Marine Fidelle, Caroline Flament, Vichnou Poirier-Colame, Paule Opolon, Christophe Klein, Kristina Iribarren, Laura Mondragón, Nicolas Jacquelot, Bo Qu, Gladys Ferrere, Céline Clémenson, Laura Mezquita, J. Remon Masip, Charles Naltet, Solenn Brosseau, Courèche Kaderbhaï, Corentin Richard, Hira Rizvi, Florence Levenez, Nathalie Galleron, Benoît Quinquis, Nicolas Pons, Bernhard Ryffel, Véronique Minard-Colin, Patrick Gonin, Jean‐Charles Soria, Éric Deutsch, Yohann Loriot, François Ghiringhelli, Gérard Zalcman, François Goldwasser, Bernard Escudier, Matthew D. Hellmann, Alexander Eggermont, Didier Raoult, Laurence Albigès, Guido Kroemer, Laurence Zitvogel - Science 2017 cited by 5,594
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Authors: Marie Vétizou, Jonathan M. Pitt, Romain Daillère, Patricia Lepage, Nadine Waldschmitt, Caroline Flament, Sylvie Rusakiewicz, Bertrand Routy, María P. Roberti, Connie P.M. Duong, Vichnou Poirier-Colame, Antoine Roux, Sonia Becharef, Silvia C. Formenti, Encouse B. Golden, Sascha Cording, Gérard Eberl, Andreas Schlitzer, Florent Ginhoux, Sridhar Mani, Takahiro Yamazaki, Nicolas Jacquelot, David Enot, M Bérard, Jérôme Nigou, Paule Opolon, Alexander Eggermont, Paul‐Louis Woerther, Élisabeth Chachaty, Nathalie Chaput, Caroline Robert, Christina Mateus, Guido Kroemer, Didier Raoult, Ivo G. Boneca, Franck Carbonnel, Mathias Chamaillard, Laurence Zitvogel - Science 2015 cited by 3,456
- Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy
Authors: Jonathan M. Pitt, Aurélien Marabelle, Alexander Eggermont, J.C. Soria, Guido Kroemer, Laurence Zitvogel - Annals of Oncology 2016 cited by 1,372
- Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
Authors: Romain Daillère, Marie Vétizou, Nadine Waldschmitt, Takahiro Yamazaki, Christophe Isnard, Vichnou Poirier-Colame, Connie P.M. Duong, Caroline Flament, Patricia Lepage, María Paula Roberti, Bertrand Routy, Nicolas Jacquelot, Lionel Apétoh, Sonia Becharef, Sylvie Rusakiewicz, Philippe Langella, Harry Sokol, Guido Kroemer, David Enot, Antoine Roux, Alexander Eggermont, Éric Tartour, Ludger Johannes, Paul‐Louis Woerther, Élisabeth Chachaty, Jean‐Charles Soria, Encouse B. Golden, Silvia C. Formenti, Magdalena Plebanski, Mutsa Madondo, Philip Rosenstiel, Didier Raoult, Vincent Cattoir, Ivo G. Boneca, Mathias Chamaillard, Laurence Zitvogel - Immunity 2016 cited by 854
- Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
Authors: Benjamin Besse, Mélinda Charrier, Valérie Lapierre, Éric Dansin, Olivier Lantz, David Planchard, Thierry Le Chevalier, Alain Livartoski, Fabrice Barlesi, Agnès Laplanche, Stéphanie Ploix, Nadège Vimond, Isabelle Péguillet, Clotilde Théry, Ludovic Lacroix, Inka Zoernig, Kavita M. Dhodapkar, Madhav V. Dhodapkar, Sophie Viaud, Jean‐Charles Soria, Katrin S. Reiners, Elke Pogge von Strandmann, Frédéric Vely, Sylvie Rusakiewicz, Alexander Eggermont, Jonathan M. Pitt, Laurence Zitvogel, Nathalie Chaput - OncoImmunology 2015 cited by 782
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Authors: Antonella Sistigu, Takahiro Yamazaki, Erika Vacchelli, Kariman Chaba, David Enot, Julien Adam, Ilio Vitale, Aïcha Goubar, Elisa Elena Baracco, Catarina Remédios, Laetitia Fend, Dalil Hannani, Laetitia Aymeric, Yuting Ma, Mireia Niso‐Santano, Oliver Kepp, Joachim L. Schultze, Thomas Tüting, Filippo Belardelli, Laura Bracci, Valentina La Sorsa, Giovanna Ziccheddu, Paola Sestili, Francesca Urbani, Mauro Delorenzi, Magali Lacroix‐Triki, Virginie Quidville, Rosa Conforti, Jean-Philippe Spano, Lajos Pusztai, Vichnou Poirier-Colame, Suzette Delaloge, Frédérique Penault‐Llorca, Sylvain Ladoire, Laurent Arnould, Joanna Cyrta, Marie-Charlotte Dessoliers, Alexander Eggermont, Marco E. Bianchi, Mikaël J. Pittet, Camilla Engblom, Christina Pfirschke, Xavier Préville, Gilles Uzé, Robert D. Schreiber, Melvyn T. Chow, Mark J. Smyth, Enrico Proietti, Fabrice André, Guido Kroemer, Laurence Zitvogel - Nature Medicine 2014 cited by 1,031
- Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
Authors: Aurélie Fluckiger, Romain Daillère, Mohamed Sassi, Barbara S. Sixt, Peng Liu, Friedemann Loos, Corentin Richard, Catherine Rabu, Maryam Tidjani Alou, Anne‐Gaëlle Goubet, Fabien Lemaître, Gladys Ferrere, Lisa Derosa, Connie P.M. Duong, Meriem Messaoudene, Andréanne Gagné, Philippe Joubert, Luisa De Sordi, Laurent Debarbieux, Sylvain Simon, Clara‐Maria Scarlata, Maha Ayyoub, Belinda Palermo, Francesco Facciolo, Romain Boidot, Richard Wheeler, Ivo G. Boneca, Zsófia Sztupinszki, Krisztián Papp, István Csabai, Edoardo Pasolli, Nicola Segata, Carlos López-Otı́n, Zoltán Szállási, Fabrice André, Valerio Iebba, Valentin Quiniou, David Klatzmann, Jacques Bou Khalil, S. Khelaifia, Didier Raoult, Laurence Albigès, Bernard Escudier, Alexander Eggermont, Fathia Mami‐Chouaib, Paola Nisticò, François Ghiringhelli, Bertrand Routy, Nathalie Labarrière, Vincent Cattoir, Guido Kroemer, Laurence Zitvogel - Science 2020 cited by 384
- Dendritic cell–derived exosomes for cancer therapy
Authors: Jonathan M. Pitt, Fabrice André, Sebastián Amigorena, Jean‐Charles Soria, Alexander Eggermont, Guido Kroemer, Laurence Zitvogel - Journal of Clinical Investigation 2016 cited by 613
- Global cancer surgery: delivering safe, affordable, and timely cancer surgery
Authors: Richard Sullivan, Olusegun Isaac Alatise, Benjamin O. Anderson, Riccardo A. Audisio, Philippe Autier, Ajay Aggarwal, Charles M. Balch, Murray F. Brennan, Anna Dare, Anil D′Cruz, Alexander Eggermont, Kenneth Fleming, Sérigne Maguèye Gueye, Lars Hagander, Cristián Herrera, Hampus Holmer, André Ilbawi, A Jarnheimer, Jiafu Ji, T. Peter Kingham, Jonathan Liberman, Andrew Leather, John G. Meara, Swagoto Mukhopadhyay, Shilpa S. Murthy, Sherif Omar, Groesbeck P. Parham, C.S. Pramesh, Robert Riviello, Danielle Rodin, Luiz Antônio Santini, Shailesh V. Shrikhande, Mark G. Shrime, Robert Thomas, Audrey Tieko Tsunoda, Cornelis J.�H. van de Velde, Umberto Veronesi, D. K. Vijaykumar, David Watters, Shan Wang, Yi‐Long Wu, Moez Zeiton, Arnie Purushotham - The Lancet Oncology 2015 cited by 685
- Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
Authors: Alexander Eggermont, Christian U. Blank, Mario Mandalà, Georgina V Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger H.T. Koornstra, Leonel F. Hernandez‐Aya, Anna Maria Di Giacomo, Alfons J.M. van den Eertwegh, Jean‐Jacques Grob, Ralf Gutzmer, Rahima Jamal, Paul Lorigan, Alexander C. J. van Akkooi, Clemens Krepler, Nageatte Ibrahim, Sandrine Marréaud, Michal Kiciński, Stefan Suciu, Caroline Robert, Alex Menzies, Thierry Lesimple, Michele Maio, Gerald P. Linette, Michael P. Brown, Peter Hersey, Inge Marie Svane, Laurent Mortier, Jacob Schachter, Catherine Barrow, Ragini R. Kudchadkar, Xinni Song, Caroline Dutriaux, Pietro Quaglino, Friedegund Meier, Paola Queirolo, Daniil Stroyakovskiy, Lars Bastholt, B. Guillot, Claus Garbe, Pablo L. Ortiz‐Romero, Florent Grange, Peter Mohr, Alain P. Algazi, Oliver Bechter, Micaela Hernberg, Jean‐Philippe Arnault, Philippe Saïag, Carmen Loquai, Frank Meiß, Jan‐Christoph Simon, Gil Bar‐Sela, Vanna Chiarion‐Sileni, Bernard M. Fitzharris, Mike McCrystal, Phillip Parente, Jean‐François Baurain, P. Combemale, Célèste Lebbé, Axel Hauschild, Naoya Yamazaki, Reinhard Dummer, Mohammed Milhem, Marcin Dzienis, John Walker, L. Geoffrois, M.‐T. Leccia, Lutz Kretschmer, Daniel Hendler, Michal Lotem, Andrzej Maćkiewicz, Lidija Kandolf Sekulović, Elaine Dunwoodie, Christoph Höeller, L. Machet, Jessica C. Hassel, Geke A.P. Hospers, Maria-Jose Passos, Max Levin, Martin Fehr, Philippa Corrie, Ashita Waterston, Sigrun Hallmeyer, Henrik Schmidt, V. Descamps, J.‐P. Lacour, Carola Berking, Felix Kiecker, Pier Francesco Ferrucci and 32 more - The Lancet Oncology 2021 cited by 389
- Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
Authors: Ketty Peris, Maria Concetta Fargnoli, Claus Garbe, Roland Kaufmann, Lars Bastholt, N. Basset Seguin, Véronique Bataille, V. del Mármol, Reinhard Dummer, Catherine Harwood, Axel Hauschild, Christoph Höller, Merete Hædersdal, Josep Malvehy, Mark R. Middleton, C.A. Morton, Eduardo Nagore, Alexander Stratigos, Rolf‐Markus Szeimies, Luca Tagliaferri, Myrto Trakatelli, Iris Zalaudek, Alexander Eggermont, Jean Jacques Grob - European Journal of Cancer 2019 cited by 590
- Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
Authors: Nicolas Jacquelot, Takahiro Yamazaki, María P. Roberti, Connie P.M. Duong, Miles C. Andrews, Loïc Verlingue, Gladys Ferrere, Sonia Becharef, Marie Vétizou, Romain Daillère, Meriem Messaoudene, David Enot, Gautier Stoll, Stefano Ugel, Ilaria Marigo, Shin Foong Ngiow, Aurélien Marabelle, Armelle Prévost‐Blondel, Pierre-Olivier Gaudreau, Vancheswaran Gopalakrishnan, Alexander Eggermont, Paule Opolon, Christophe Klein, Gabriele Madonna, Paolo A. Ascierto, Antje Sucker, Dirk Schadendorf, Mark J. Smyth, Jean‐Charles Soria, Guido Kroemer, Vincenzo Bronte, Jennifer A. Wargo, Laurence Zitvogel - Cell Research 2019 cited by 248
- Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer
Authors: María Paula Roberti, Satoru Yonekura, Connie P.M. Duong, Marion Picard, Gladys Ferrere, Maryam Tidjani Alou, Conrad Rauber, Valerio Iebba, Christian H.K. Lehmann, Lukas Amon, Diana Dudziak, Lisa Derosa, Bertrand Routy, Caroline Flament, Corentin Richard, Romain Daillère, Aurélie Fluckiger, Isabelle Van Seuningen, Mathias Chamaillard, Audrey Vincent, Stephanie Kourula, Paule Opolon, Pierre Ly, Eugénie Pizzato, Sonia Becharef, Juliette Paillet, Christophe Klein, Florence Marliot, Filippo Pietrantonio, Stéphane Benoist, Jean‐Yves Scoazec, Peggy Dartigues, Antoine Hollebecque, David Malka, Franck Pagès, Jérôme Galon, Ivo G. Boneca, Patricia Lepage, Bernard Ryffel, Didier Raoult, Alexander Eggermont, Tom Vanden Berghe, François Ghiringhelli, Peter Vandenabeele, Guido Kroemer, Laurence Zitvogel - Nature Medicine 2020 cited by 196
- Trial watch: IDO inhibitors in cancer therapy
Authors: Erika Vacchelli, Fernando Aranda, Alexander Eggermont, Catherine Sautès‐Fridman, Éric Tartour, Eugene P. Kennedy, Michael Platten, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi - OncoImmunology 2014 cited by 325
- Classification of current anticancer immunotherapies
Authors: Lorenzo Galluzzi, Erika Vacchelli, José Manuel Bravo‐San Pedro, Aitziber Buqué, Laura Senovilla, Elisa Elena Baracco, Norma Bloy, Francesca Castoldi, Jean-Pierre Abastado, Patrizia Agostinis, Ron N. Apte, Fernando Aranda, Maha Ayyoub, Philipp Beckhove, Jean‐Yves Blay, Laura Bracci, Anne Caignard, Chiara Castelli, Federica Cavallo, Estaban Celis, Vincenzo Cerundolo, Aled Clayton, Mario P. Colombo, Lisa M. Coussens, Madhav V. Dhodapkar, Alexander Eggermont, Douglas T. Fearon, Wolf H. Fridman, Jitka Fučíková, Dmitry I. Gabrilovich, Jérôme Galon, Abhishek D. Garg, François Ghiringhelli, Giuseppe Giaccone, Eli Gilboa, Sacha Gnjatic, Axel Hoos, Anne Hosmalin, Dirk Jäger, Paweł Kaliński, Klas Kärre, Oliver Kepp, Rolf Kiessling, John M. Kirkwood, Eva Klein, Alexander Knuth, Claire E. Lewis, Roland Liblau, Michael T. Lotze, Enrico Lugli, J P Mach, Fabrizio Mattei, Domenico Mavilio, Ignacio Melero, Cornelis J.M. Melief, Elizabeth A. Mittendorf, Lorenzo Moretta, Adekunke Odunsi, Hideho Okada, A. Karolina Palucka, Marcus E. Peter, Kenneth J. Pienta, Angel Porgador, George C. Prendergast, Gabriel A. Rabinovich, Nicholas P. Restifo, Naiyer A. Rizvi, Catherine Sautès‐Fridman, Hans Schreiber, Barbara Seliger, Hiroshi Shiku, Bruno Silva‐Santos, Mark J. Smyth, Daniel E. Speiser, Radek Špíšek, Pramod K. Srivastava, James E. Talmadge, Éric Tartour, Sjoerd H. van der Burg, Benoı̂t J. Van den Eynde, Richard G. Vile, Hermann Wagner, Jeffrey S. Weber, Theresa L. Whiteside, Jedd D. Wolchok, Laurence Zitvogel, Weiping Zou, Guido Kroemer - Oncotarget 2014 cited by 470
- Delivering affordable cancer care in high-income countries
Authors: Richard Sullivan, Jeffrey Peppercorn, Karol Sikora, John Zalcberg, Neal J. Meropol, Eitan Amir, David Khayat, Peter Boyle, Philippe Autier, Ian F. Tannock, Tito Fojo, Jim Siderov, Steve Williamson, Silvia Camporesi, J. Gordon McVie, Arnie Purushotham, Peter Naredi, Alexander Eggermont, Murray F. Brennan, Michael L. Steinberg, Mark De Ridder, Susan A. McCloskey, Dirk Verellen, Terence Roberts, Guy Storme, Rodney J. Hicks, Peter J. Ell, Bradford R. Hirsch, David P. Carbone, Kevin A. Schulman, Paul Catchpole, David Taylor, Jan Geißler, Nancy Brinker, David Meltzer, David Kerr, Matti Aapro - The Lancet Oncology 2011 cited by 714
- Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy
Authors: Jonathan Pol, Erika Vacchelli, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Catherine Sautès‐Fridman, Jitka Fučíková, Jérôme Galon, Radek Špíšek, Éric Tartour, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi - OncoImmunology 2015 cited by 297
- Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
Authors: Erika Vacchelli, Lorenzo Galluzzi, Alexander Eggermont, Wolf H. Fridman, Jérôme Galon, Catherine Sautès‐Fridman, Éric Tartour, Laurence Zitvogel, Guido Kroemer - OncoImmunology 2012 cited by 245
- Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer
Authors: Gonzalo Recondo, Laura Mezquita, Francesco Facchinetti, David Planchard, Anas Gazzah, Ludovic Bigot, Ahsan Z. Rizvi, Rosa L. Frias, Jean Paul Thiery, Jean‐Yves Scoazec, Tony Sourisseau, Karen Howarth, Olivier Déas, Dariia Samofalova, Justine Galissant, Pauline Tesson, Floriane Brayé, Charles Naltet, Pernelle Lavaud, Linda Mahjoubi, Aurélie Abou Lovergne, Gilles Vassal, Rastilav Bahleda, Antoine Hollebecque, Claudio Nicotra, Maud Ngo‐Camus, Stefan Michiels, Ludovic Lacroix, Catherine Richon, Nathalie Auger, Thierry de Baère, Lambros Tselikas, Éric Solary, Eric Angevin, Alexander Eggermont, Fabrice André, Christophe Massard, Ken A. Olaussen, Jean‐Charles Soria, Benjamin Besse, Luc Friboulet - Clinical Cancer Research 2019 cited by 167
- Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial
Authors: Carolina Alves Costa Silva, Gianmarco Piccinno, Déborah Suissa, Mélanie Bourgin, Gerty Schreibelt, Sylvère Durand, Roxanne Birebent, Marine Fidelle, Cissé Sow, Fanny Aprahamian, Paolo Manghi, Michal Punčochář, Francesco Asnicar, Federica Pinto, Federica Armanini, Safae Terrisse, Bertrand Routy, Damien Drubay, Alexander Eggermont, Guido Kroemer, Nicola Segata, Laurence Zitvogel, Lisa Derosa, Kalijn F. Bol, I. Jolanda M. de Vries - Nature Communications 2024 cited by 29
- Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma
Authors: NCI DCEG Cancer Sequencing Working Group, Jianxin Shi, French Familial Melanoma Study Group, Xiaohong R. Yang, Bari J. Ballew, Melissa Rotunno, Donato Calista, Maria Concetta Fargnoli, Paola Ghiorzo, Brigitte Bressac–de Paillerets, Eduardo Nagore, M.-F. Avril, Neil E. Caporaso, Mary L. McMaster, Michael Cullen, Zhaoming Wang, Xijun Zhang, William Bruno, Lorenza Pastorino, Paola Queirolo, José Bañuls‐Roca, Zaida García‐Casado, Amaury Vaysse, Hamida Mohamdi, Yasser Riazalhosseini, Mario Foglio, Fanélie Jouenne, Xing Hua, Paula L. Hyland, Jinhu Yin, Haritha Vallabhaneni, Weihang Chai, Paola Minghetti, Cristina Pellegrini, Sarangan Ravichandran, Alexander Eggermont, Mark Lathrop, Ketty Peris, Giovanna Bianchi‐Scarrà, G Landi, Sharon A. Savage, Joshua N. Sampson, Ji He, Meredith Yeager, Lynn R. Goldin, Florence Démenais, Stephen J. Chanock, Margaret A. Tucker, Alisa M. Goldstein, Yie Liu, Maria Teresa Landi - Nature Genetics 2014 cited by 333
- Predictors of responses to immune checkpoint blockade in advanced melanoma
Authors: Nicolas Jacquelot, María P. Roberti, David Enot, Sylvie Rusakiewicz, Nils Ternès, Sarah Jégou, David Woods, Andressa L. Sodré, Morten Hansen, Yaron Meirow, Moshe Sade-Feldman, Abhishek Burra, Serena S. Kwek, Caroline Flament, Meriem Messaoudene, Connie P.M. Duong, Lieping Chen, Byoung S. Kwon, Ana C. Anderson, Vijay K. Kuchroo, Benjamin Weide, F. Aubin, Christophe Borg, Stéphane Dalle, O. Beatrix, Maha Ayyoub, B. Balme, Gorana Tomasic, Anna Maria Di Giacomo, Massimo Di Maïo, Dirk Schadendorf, Ignacio Melero, Brigitte Dréno, Amir Khammari, Reinhard Dummer, Mitchell P. Levesque, Yoshinobu Koguchi, Lawrence Fong, Michal Lotem, Michal Baniyash, Henrik Schmidt, Inge Marie Svane, Guido Kroemer, Aurélien Marabelle, Stefan Michiels, Andréa Cavalcanti, Mark J. Smyth, Jeffrey S. Weber, Alexander Eggermont, Laurence Zitvogel - Nature Communications 2017 cited by 201
- Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel–Lindau Gene Mutation Status
Authors: Yosra Messai, Sophie Gad, Muhammad Zaeem Noman, Gwénaël Le Teuff, Sophie Couvé, Bassam Janji, Solenne Florence Kammerer, Nathalie Rioux-Leclerc, Meriem Hasmim, Sophie Ferlicot, Véronique Baud, Arnaud Méjean, David R. Mole, Stéphane Richard, Alexander Eggermont, Laurence Albigès, Fathia Mami‐Chouaib, Bernard Escudier, Salem Chouaı̈b - European Urology 2015 cited by 176
- Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review
Authors: Justyna Mierzynska, Claire Piccinin, Madeline Pe, Francesca Martinelli, Carolyn Gotay, Corneel Coens, Murielle Mauer, Alexander Eggermont, Mogens Grøenvold, Kristin Bjordal, Jaap C. Reijneveld, Galina Velikova, Andrew Bottomley - The Lancet Oncology 2019 cited by 129
